Suppr超能文献

流式细胞术分析肺癌进展过程中胸腔积液中的细胞DNA含量:一例报告

Analysis of Cellular DNA Content in Pleural Effusion by Flow Cytometry During Lung Cancer Progression: A Case Report.

作者信息

Vasilescu Maria M, Panait Marieta E, Dumitru Mirela

机构信息

Department of Cancer Biochemistry and Radiobiology, Institutul Oncologic Prof. Dr. Alexandru Trestioreanu, Bucharest, ROU.

Department of Cancer Biology, Institutul Oncologic Prof. Dr. Alexandru Trestioreanu, Bucharest, ROU.

出版信息

Cureus. 2024 Dec 22;16(12):e76208. doi: 10.7759/cureus.76208. eCollection 2024 Dec.

Abstract

Malignant pleural effusion (MPE) is a common feature in patients with advanced or metastatic malignancies. While significant progress has been made in understanding the biology of pleural effusions, further research is needed to uncover the subsequent behavior of tumor cells following their invasion into the pleural space. This report utilizes flow cytometry to analyze DNA content abnormalities (aneuploidy) and cell cycle status, shedding light on the tumor cell populations present in MPE samples from a patient with lung adenocarcinoma during treatment. The findings suggest that under selective pressure, certain tumor cell subpopulations within the pleural effusion were suppressed, while therapy-resistant subpopulations emerged, driving disease progression. MPE serves as a valuable model for studying tumor heterogeneity and clonal dynamics in real time, offering insights that may inform diagnosis, prognosis, and therapeutic strategies.

摘要

恶性胸腔积液(MPE)是晚期或转移性恶性肿瘤患者的常见特征。虽然在理解胸腔积液生物学方面已取得重大进展,但仍需进一步研究以揭示肿瘤细胞侵入胸腔后的后续行为。本报告利用流式细胞术分析DNA含量异常(非整倍体)和细胞周期状态,以阐明一名肺腺癌患者治疗期间MPE样本中存在的肿瘤细胞群体。研究结果表明,在选择性压力下,胸腔积液中的某些肿瘤细胞亚群受到抑制,而出现了抗治疗亚群,推动疾病进展。MPE作为实时研究肿瘤异质性和克隆动态的宝贵模型,可为诊断、预后和治疗策略提供见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/835e/11750209/f04f5fc8ec37/cureus-0016-00000076208-i01.jpg

相似文献

1
Analysis of Cellular DNA Content in Pleural Effusion by Flow Cytometry During Lung Cancer Progression: A Case Report.
Cureus. 2024 Dec 22;16(12):e76208. doi: 10.7759/cureus.76208. eCollection 2024 Dec.
3
Quantitative proteomics revealed protein biomarkers to distinguish malignant pleural effusion from benign pleural effusion.
J Proteomics. 2024 Jun 30;302:105201. doi: 10.1016/j.jprot.2024.105201. Epub 2024 May 18.
7
mRNA markers associated with malignant pleural effusion.
Sci Rep. 2023 Apr 24;13(1):6677. doi: 10.1038/s41598-023-32872-2.
9
Variations in pleural microbiota and metabolic phenotype associated with malignant pleural effusion in human lung adenocarcinoma.
Thorac Cancer. 2023 Jul;14(21):2045-2056. doi: 10.1111/1759-7714.14988. Epub 2023 Jun 12.
10
Cytotoxic Natural Killer Subpopulations as a Prognostic Factor of Malignant Pleural Effusion.
Lung. 2019 Feb;197(1):53-60. doi: 10.1007/s00408-018-0186-7. Epub 2018 Dec 6.

本文引用的文献

1
Clinical Applications of Aneuploidies in Evolution of NSCLC Patients: Current Status and Application Prospect.
Onco Targets Ther. 2022 Nov 10;15:1355-1368. doi: 10.2147/OTT.S380016. eCollection 2022.
2
Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy.
Genome Med. 2022 Aug 11;14(1):86. doi: 10.1186/s13073-022-01090-2.
3
Gene copy-number changes and chromosomal instability induced by aneuploidy confer resistance to chemotherapy.
Dev Cell. 2021 Sep 13;56(17):2440-2454.e6. doi: 10.1016/j.devcel.2021.07.006. Epub 2021 Aug 4.
4
Chromosomal instability accelerates the evolution of resistance to anti-cancer therapies.
Dev Cell. 2021 Sep 13;56(17):2427-2439.e4. doi: 10.1016/j.devcel.2021.07.009. Epub 2021 Aug 4.
5
Aneuploidy increases resistance to chemotherapeutics by antagonizing cell division.
Proc Natl Acad Sci U S A. 2020 Dec 1;117(48):30566-30576. doi: 10.1073/pnas.2009506117. Epub 2020 Nov 17.
6
Genetic heterogeneity and clonal evolution during metastasis in breast cancer patient-derived tumor xenograft models.
Comput Struct Biotechnol J. 2020 Jan 31;18:323-331. doi: 10.1016/j.csbj.2020.01.008. eCollection 2020.
7
Malignant Pleural Effusion and Its Current Management: A Review.
Medicina (Kaunas). 2019 Aug 15;55(8):490. doi: 10.3390/medicina55080490.
8
Investigating unilateral pleural effusions: the role of cytology.
Eur Respir J. 2018 Nov 8;52(5). doi: 10.1183/13993003.01254-2018. Print 2018 Nov.
9
Diagnosis and management options in malignant pleural effusions.
Lung India. 2017 Mar-Apr;34(2):160-166. doi: 10.4103/0970-2113.201305.
10
Breast cancer intra-tumor heterogeneity.
Breast Cancer Res. 2014 May 20;16(3):210. doi: 10.1186/bcr3658.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验